IPO Premiums
IPO calendar
MPListed

Mankind Pharma Limited

Bookbuilding IPO · NSE, BSE

Price band
₹1026 - ₹1080
Lot size
13 shares
Issue amount
₹4,326.36 cr
Total subscription
15.32×
Current price₹2,253.2
Listing price ₹1,300
Watch live price ↗
Opens
25 Apr 2023
Closes
27 Apr 2023
Allotment
4 May 2023
Listing
9 May 2023

Offer at a glance

Issue overview

Issue size
4,00,58,844 shares
Face value
₹1 Per Share
Minimum investment
₹13,338
Fresh issue
₹0 cr
Offer for sale
₹4,326.36 cr
Registrar
KFin Technologies Limited
Listing exchange
NSE, BSE
Maximum investment
₹14,040
Issue type
Bookbuilding IPO
Shares before issue
40,05,88,440
Shares after issue
40,05,88,440

Lot sizes

CategoryLotsSharesAmount
RETAIL113₹14,040
sHNI15195₹2,10,600
bHNI72936₹10,10,880

Share reservation

QIB50%
NII (HNI)15%
RETAIL35%

Subscription & GMP

Subscription by category

Total subscribed15.32×

Missing multiples are calculated from bids and offered shares when available.

QIB51.74×
NIB4×
HNIs(10L +)5.26×
HNIs (2-10L)1.48×
RETAIL0.97×

GMP history

09018021 Mar: ₹18020 May: ₹180
21 Mar₹18020 May

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs822.0142,534.08
RETAIL1,438.511,388.45
HNIs 2+205.5304.8
HNIs 10+4112,160.05

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profit In Crores
02,0004,0006,0008,000Dec 2022 · Revenue: 6,777.82Dec 2022 · Profit after tax: 1,015.98Dec 2022Mar 2022 · Revenue: 7,977.58Mar 2022 · Profit after tax: 1,452.96Mar 2022Dec 2021 · Revenue: 6,218.29Dec 2021 · Profit after tax: 1,260.24Dec 2021Mar 2021 · Revenue: 6,385.38Mar 2021 · Profit after tax: 1,293.03Mar 2021Mar 2020 · Revenue: 5,975.65Mar 2020 · Profit after tax: 1,056.15Mar 2020
RevenueProfit after tax

Key performance indicators

MetricValues
33.2033.2
ROE27.6
ROCE26.1
27.7027.7
33.2032.5
00

Values and labels as reported in the issue data.

Company information

Company profile

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products across a wide range of acute and chronic therapeutic areas in India, including anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/CNS, vitamins/minerals/nutrients, and respiratory. The company offers over 36 brands such as Manforce, Moxikind-CV, Amlokind-AT, Prega News, and Gudcef, supported by one of the largest distribution networks of medical representatives in India, with over 80% of doctors prescribing its formulations. Ranked 4th in domestic sales in FY2022, Mankind Pharma has received numerous awards, including The Best of Bharat Awards 2022, National Awards for Manufacturing Competitiveness Silver Medal 2021, and recognition for Best Design in Healthcare and performance management excellence.

Promoters

Ramesh Juneja

Rajeev Juneja

Sheetal Arora

Ramesh Juneja Family Trust

Rajeev Juneja Family Trust

Prem Sheetal Family Trust

Registrar & documents

Lead manager

Kotak Mahindra Capital Company, Axis Capital Limited, IIFL Capital Services Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited

Registered office

208, Okhla Industrial Estate Phase-III, New Delhi 110020

+91 11 4684 6700

[email protected]Company website ↗

Frequently Asked Questions

What is Mankind Pharma IPO GMP today?

As of today, Mankind Pharma IPO Grey Market Premium (GMP) is reported at +₹180 per share. Based on the upper price band of ₹1,080, the estimated listing price is ₹1,260 (+16.7% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.

What is the lot size and minimum investment for Mankind Pharma IPO?

The minimum bid lot size for Mankind Pharma IPO is 13 shares. At the cut-off price of ₹1,080 per share, retail investors need a minimum application amount of ₹14,040 per lot. Retail applicants can apply for a maximum of 14 lots (up to ₹2,00,000).

When will Mankind Pharma IPO allotment status be announced?

The allotment status for Mankind Pharma IPO is scheduled to be finalized on 4 May 2023. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through KFin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Mankind Pharma IPO allotment status online by PAN?

To check Mankind Pharma IPO allotment status: 1) Visit the registrar portal (KFin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Mankind Pharma Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.
Mankind Pharma IPO GMP Today, Subscription Status & Allotment Date | IPO Premiums